Cigna Corp (NY:CI)

The End of the Flywheel? DOJ Intensifies Structural Challenge Against UnitedHealth’s Vertical Empire

Topics ETFs

April 08, 2026

The Department of Justice’s long-standing pursuit of UnitedHealth Group (NYSE: UNH) has reached a fever pitch. As of April 8, 2026, the nation’s largest healthcare conglomerate finds itself entrenched...

Over the last six months, Cigna shares have sunk to $277.13, producing a disappointing 9.7% loss - worse than the S&P 500’s 2.1% drop. This might have invest...

Topics Lawsuit

2 Reasons to Watch CI and 1 to Stay Cautious

April 08, 2026

As UNH shares pop higher, consider the iShares U.S. Healthcare Providers ETF too.

Topics Stocks Supply Chain

If You Are Buying Into the Comeback Story in UnitedHealth Stock, Buy This ETF Too

April 07, 2026

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...

Topics ETFs Stocks

1 Value Stock to Keep an Eye On and 2 We Avoid

April 03, 2026

April 2, 2026 Introduction The Cigna Group (NYSE: CI) stands today at a pivotal crossroads, having undergone one of the most significant strategic transformations in the modern healthcare era. Long...

The Evolution of The Cigna Group: A Deep Dive into a Health Services Powerhouse (2026)

April 02, 2026

Via Finterra

Topics Artificial Intelligence Economy Lawsuit

The Great Disconnect: Why Analysts See 45% Upside in Adobe and Cigna Amid Market Skepticism

March 30, 2026

As of March 30, 2026, a peculiar divergence has emerged in the equity markets, where two of the most consistent cash-flow generators in the S&P 500 are trading at valuations reminiscent of a deep...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Topics Artificial Intelligence Earnings Economy

1 Cash-Producing Stock Worth Your Attention and 2 We Find Risky

March 30, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

1 Healthcare Stock Worth Investigating and 2 That Underwhelm

March 27, 2026

LifeStance Health (LFST) Surge: Inside the Turnaround of America’s Mental Health Powerhouse

March 24, 2026

On this Tuesday, March 24, 2026, the healthcare sector is witnessing a dramatic rally in shares of LifeStance Health Group, Inc. (NASDAQ: LFST). The stock is surging double digits in early trading...

Via Finterra

Topics Artificial Intelligence Initial Public Offering

Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? ↗

March 20, 2026

Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals.

This clinical-stage biotech develops precision therapies for genetically defined diseases, targeting rare cancers and systemic mastocytosis.

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗

March 20, 2026

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position ↗

Topics Regulatory Compliance

March 20, 2026

This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance mechanisms.

HealthEquity delivers cloud-based healthcare savings solutions to employers and individuals, with a broad client network across the U.S.

Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy? ↗

March 15, 2026

UnitedHealth Plunge: Market Reeling as First Revenue Contraction in 30 Years Meets Trump's Medicare Squeeze

March 11, 2026

The healthcare investment landscape was irrevocably altered this quarter as UnitedHealth Group (NYSE:UNH) witnessed a historic 20% collapse in its market valuation. The blue-chip titan, long considered...

Humana has notably underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

Topics Earnings Economy Government

Is Humana Stock Underperforming the S&P 500?

March 09, 2026

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, i...

Topics Stocks

Health Insurance Providers Stocks Q4 Recap: Benchmarking Cigna (NYSE:CI)

March 08, 2026

Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know

Topics Artificial Intelligence Economy Fraud

Here's How Much $1000 Invested In Cigna Group 15 Years Ago Would Be Worth Today ↗

March 06, 2026

Via Benzinga

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Cigna announced earlier on Tuesday that David M. Cordani will retire as CEO effective July 1, 2026, to be succeeded by Brian Evanko.

Topics Economy

Cigna Group Announces New CEO; Wall Street Admits Surprise But Remains Bullish ↗

March 03, 2026

Via Stocktwits

Topics Retirement

Cigna Stock Falls After CEO Retirement Announcement ↗

March 03, 2026

The Cigna Group (NYSE:CI) shares are trading lower Tuesday after the company announced that David Cordani will retire as CEO.

Via Benzinga

Topics Retirement

Is Elevance Health Stock Underperforming the Dow?

March 02, 2026

Elevance Health has lagged behind the broader Dow Jones Industrial Average over the past year, and analysts are cautiously bullish about its future prospects.

Over the last six months, Abbott Laboratories’s shares have sunk to $116.31, producing a disappointing 11.5% loss - a stark contrast to the S&P 500’s 7.7% gain. This was partly driven by its softer...

Topics Stocks

2 Reasons to Like ABT and 1 to Stay Skeptical

March 01, 2026

Cigna Group shows mixed price performance, yet sound fundamentals support analyst conviction for continued growth.

Topics Stocks Supply Chain

Is Cigna Group Stock Underperforming the Dow?

February 27, 2026

Pacira (PCRX) Q4 2025 Earnings Call Transcript

Topics Stocks

Pacira (PCRX) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Over the past six months, Molina Healthcare’s shares (currently trading at $145.75) have posted a disappointing 16.6% loss, well below the S&P 500’s 6.5% gain. This was partly due to its softer...

Topics Earnings Intellectual Property

Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today ↗

February 26, 2026

Via Benzinga

Molina Healthcare (MOH): Buy, Sell, or Hold Post Q4 Earnings?

February 25, 2026

The Great Managed Care Reset: UnitedHealth’s 2025 Profit Slump Signals a New Era of Austerity for Medicare Advantage

Topics Stocks Supply Chain

February 25, 2026

The "golden era" of the managed care sector came to an abrupt and painful halt this year, as UnitedHealth Group (NYSE: UNH) reported a staggering 16% decline in full-year 2025 net profits. This...

Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow after market hours. Here’s what to look for.

Topics Earnings Economy

Clover Health (CLOV) To Report Earnings Tomorrow: Here Is What To Expect

February 25, 2026